Arkolith/Insider Trading/BIAF/Form 4

Girgenti Steven

Executive Chairman, DirectorbioAffinity Technologies, Inc. (BIAF) · full profile →Form 4 · filed Nov 8, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
39
16 non-derivative · 23 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 6, 2022Conversion(C)8K$4.20$32K8K
Sep 6, 2022Conversion(C)59K$4.20$247K531K
Sep 6, 2022Conversion(C)27K$4.20$115K559K
Sep 6, 2022Conversion(C)5K$4.20$21K564K
Sep 6, 2022Conversion(C)3K$4.20$11K566K
Sep 6, 2022Conversion(C)13K$4.20$56K580K
Sep 6, 2022Conversion(C)11K$4.20$45K590K
Sep 6, 2022Conversion(C)39K$4.20$165K630K
Sep 6, 2022Conversion(C)16K$4.20$66K645K
Sep 6, 2022Conversion(C)36K$4.20$151K681K
Sep 6, 2022Conversion(C)139K$3.60$500K820K
Sep 6, 2022Conversion(C)1K$7.70$10K9K
Sep 6, 2022Conversion(C)157K$4.20$658K406K
Sep 6, 2022Conversion(C)59K$4.20$248K473K
Sep 6, 2022Conversion(C)8K$4.20$32K414K
Aug 31, 2022Buy(P)41K——861K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 6, 2022Conversion(C)0—$00
Sep 6, 2022Conversion(C)0—$00
Sep 6, 2022Buy(P)0——6K
Sep 6, 2022Conversion(C)0—$00
Sep 6, 2022Grant(A)0——88K
Sep 6, 2022Grant(A)0——36K
Sep 6, 2022Grant(A)0——222K
Sep 6, 2022Conversion(C)973K—$00
Sep 6, 2022Conversion(C)9K—$00
Sep 6, 2022Conversion(C)41K—$00
Sep 6, 2022Conversion(C)41K—$00
Sep 6, 2022Conversion(C)222K—$00
Sep 6, 2022Conversion(C)6K—$00
Sep 6, 2022Conversion(C)88K—$00
Sep 6, 2022Conversion(C)36K—$00
Sep 6, 2022Conversion(C)124K—$00
Sep 6, 2022Conversion(C)2K—$00
Sep 6, 2022Conversion(C)0—$00
Sep 6, 2022Conversion(C)0—$00
Aug 31, 2022Buy(P)0——41K
Aug 31, 2022Buy(P)0——41K
Jul 20, 2022Grant(A)0——124K
Jul 20, 2022Buy(P)0——2K

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-030872) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for bioAffinity Technologies, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp